This message was sent to ##Email##
|
|
|
|
|
New Scientist
We’ve known for some time that a woman’s risk of breast cancer is reduced by both the number of children she has and at what age she gives birth to them — although exactly why is a mystery. A new study of the populations of Denmark and Norway offers clues.
READ MORE
HealthCanal.com
A preliminary study of a new, quick and accurate bedside blood test performed in emergency departments could help reduce the time it takes to rule out heart attacks. The study findings have been published in the Journal of the American Medical Association.
READ MORE
|
Promoted by
|
|
|
|
 |
Columbia University Mailman School of Public Health via Lab Manager
Scientists at the Center for Infection and Immunity in the Columbia University Mailman School of Public Health have developed the first diagnostic platform that can simultaneously screen for all known human pathogenic bacteria as well as markers for virulence and antibiotic resistance. A study in the journal mBio provides details on the performance of the BacCapSeq platform.
READ MORE
|
|
Medical News Today
A recent clinical trial could change the face of therapy for a very aggressive and stubborn form of breast cancer: triple-negative. A combination of chemotherapy and immunotherapy boosts survival rates, the scientists found.
READ MORE
 |
|
Prepare for leadership in a fast-growing field with the M.S. in Medical Laboratory Science at the University of Vermont, a Public Ivy and top 100 research university where close faculty-student mentorship enables the study of medical laboratory science emphasizing research, teaching, and advanced clinical practice.
|
|
CNRS via ScienceDaily
On Sept. 26, the United Nations announced a plan to raise $13 billion annually for the fight to eradicate tuberculosis by 2030. With 10 million new cases and 1.6 million deaths in 2017, it is the most common infectious disease in the world, ahead of HIV.
READ MORE
DARK Daily
There’s a new insurance/payer industry tactic in town and DARK Daily thinks clinical laboratories and anatomic pathology groups should know about it. It’s called a “copay accumulator,” and it was designed by payers in response to pharmaceutical company copay assistance cards and discount coupons.
READ MORE
|
|
MedPage Today
On Oct. 17, the World Health Organization stopped short of declaring a "public health emergency of international concern" for the Ebola virus outbreak in the Democratic Republic of the Congo. This decision was made amidst escalating and deadly military conflict in the outbreak epicenter, a growing incidence of infection, a very high risk of national and regional spread, a high rate of infection among healthcare workers and no conclusive empirical evidence of the effectiveness of rVSV-ZEBOV, the experimental Ebola vaccine currently in use.
READ MORE
Baylor College of Medicine via ScienceDaily
In the largest clinical microbiome study in infants reported to date, a team led by researchers at Baylor College of Medicine explored the sequence of microbial colonization in the infant gut through age 4 and found distinct stages of development in the microbiome that were associated with early life exposures. Published in the journal Nature, their report and an accompanying report led by the Broad Institute are the result of extensive analysis of data collected from a cohort of participants involved in the TEDDY diabetes study.
READ MORE
|
|
MIT News Office
Patients with blood cancers such as leukemia and lymphoma are often treated by irradiating their bone marrow to destroy the diseased cells. After the treatment, patients are vulnerable to infection and fatigue until new blood cells grow back.
READ MORE
|
Is regenerative medicine the next big thing in Hematology testing?
Learn More
|
|
|
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests. Learn more
|
|
|
|
McMaster University via Infection Control Today
Researchers at McMaster University have solved a vexing problem by engineering surface coatings that can repel everything, such as bacteria, viruses and living cells, but can be modified to permit beneficial exceptions.
The discovery holds significant promise for medical and other applications, making it possible for implants such as vascular grafts, replacement heart valves and artificial joints to bond to the body without risk of infection or blood clotting.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
